Growing community of inventors

Vence, France

Sandrine Talano

Average Co-Inventor Count = 4.16

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 7

Sandrine TalanoJean-Guy Boiteau (4 patents)Sandrine TalanoCorinne Millois Barbuis (4 patents)Sandrine TalanoThibaud Biadatti (3 patents)Sandrine TalanoSebastien Daver (3 patents)Sandrine TalanoLaurence Dumais (3 patents)Sandrine TalanoCatherine Soulet (3 patents)Sandrine TalanoKarine Bouquet (3 patents)Sandrine TalanoSébastien Daver (0 patent)Sandrine TalanoSandrine Talano (7 patents)Jean-Guy BoiteauJean-Guy Boiteau (34 patents)Corinne Millois BarbuisCorinne Millois Barbuis (8 patents)Thibaud BiadattiThibaud Biadatti (19 patents)Sebastien DaverSebastien Daver (5 patents)Laurence DumaisLaurence Dumais (5 patents)Catherine SouletCatherine Soulet (4 patents)Karine BouquetKarine Bouquet (4 patents)Sébastien DaverSébastien Daver (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Galderma Research & Development (7 from 222 patents)


7 patents:

1. 8993596 - 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics

2. 8697726 - 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics

3. 8470871 - Ligands that modulate RAR receptors

4. 8299259 - 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics

5. 8227507 - Ligands that modulate RAR receptors

6. 8119674 - 4-phenylimidazole-2-thione tyrosinase inhibitors and pharmaceutical/cosmetic applications thereof

7. 7807708 - Ligands that modulate RAR receptors and pharmaceutical/cosmetic compositions comprised thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/7/2025
Loading…